Montelukast Sodium Tablet, Film Coated
Product Images NDC 29300-220

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 29300-220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ecb8c513 E5ee 4501 A240 B2d644615559 01

A line graph comparing change in height (cm) over weeks on treatment among subjects using Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and placebo. The x-axis shows weeks on treatment from -19 to 56, and the y-axis shows change in height from -3 to 7 cm. Three distinct lines represent each treatment group with respective markers.*

FDA Label Image

Ecb8c513 E5ee 4501 A240 B2d644615559 02

Chemical structure diagram of montelukast sodium, showing its atomic and bond arrangement including chlorine, sulfur, sodium carboxylate, and multiple aromatic rings.*

FDA Label Image

Ecb8c513 E5ee 4501 A240 B2d644615559 03

A line graph depicting mean percent change from baseline over weeks in treatment comparing Montelukast Sodium and placebo. The x-axis represents weeks in treatment (0, 3, 6, 9, 12, and washout at 15 weeks), and the y-axis shows mean percent change. Montelukast Sodium shows a higher mean percent change than placebo throughout the treatment period, with a decline during the washout phase.*

FDA Label Image

Ecb8c513 E5ee 4501 A240 B2d644615559 04

Label for Montelukast Sodium Tablets, USP 10 mg by Unichem Pharmaceuticals (USA), Inc. The label includes the NDC 29300-220-13, details the tablet strength of 10 mg, and indicates the package contains 30 tablets. Manufacturer and distributor information is provided, including Unichem Laboratories Ltd. in India and Unichem Pharmaceuticals (USA), Inc. in New Jersey. Storage instructions and a barcode are also visible.*

FDA Label Image

Ecb8c513 E5ee 4501 A240 B2d644615559 05

Label for Montelukast Sodium chewable tablets, USP 5 mg strength, intended for pediatric patients aged 6 to 14 years. The bottle contains 30 chewable tablets. The label includes storage instructions, phenylketonurics warning, and manufacturer details as Unichem Laboratories Ltd. and Unichem Pharmaceuticals (USA), Inc.*

FDA Label Image

Ecb8c513 E5ee 4501 A240 B2d644615559 06

Label for Montelukast Sodium 4 mg chewable tablets, USP, for pediatric patients aged 2 to 5 years. The label states each chewable tablet contains Montelukast Sodium USP 4.2 mg equivalent to Montelukast 4 mg. The package contains 30 tablets and is manufactured by Unichem Laboratories Ltd. and labeled by Unichem Pharmaceuticals (USA), Inc. The label includes storage instructions and warnings to keep out of reach of children.*

FDA Label Image

Ecb8c513 E5ee 4501 A240 B2d644615559 907 2

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.